XML 64 R51.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION - Summary of stock options and stock options with market conditions (Details)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Stock options, Grant Date Fair Value Valuation  
Share price (in dollars per share) | $ / shares $ 213.00
Grant date fair value (in dollars per share) | $ / shares $ 136.23
Option  
Stock options, Shares  
Outstanding at the beginning of the period (in shares) | shares 924,710
Granted (in shares) | shares 53,173
Exercised (in shares) | shares (635)
Forfeited (in shares) | shares (2,280)
Expired (in shares) | shares (35)
Outstanding at the end of the period (in shares) | shares 974,933
Options exercisable at the end of the period (in shares) | shares 694,184
Stock options, Weighted Average Exercise Price  
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 111.82
Granted (in dollars per share) | $ / shares 253.75
Exercised (in dollars per share) | $ / shares 271.96
Forfeited (in dollars per share) | $ / shares 267.17
Expired (in dollars per share) | $ / shares 371.25
Outstanding at the end of the period (in dollars per share) | $ / shares 119.09
Options exercisable at the end of the period (in dollars per share) | $ / shares $ 55.13
Stock options, Weighted Average Remaining Contractual Term  
Outstanding at the end of the period 4 years 6 months 7 days
Options exercisable at the end of the period 2 years 7 months 24 days
Stock options, Aggregate Intrinsic Value  
Outstanding at the end of the period | $ $ 114,706,000
Options exercisable at the end of the period | $ $ 114,701,000
Stock options, Grant Date Fair Value Valuation  
Vesting period 3 years
Expected term 6 years
Expected dividend rate 0.00%
Expected volatility rate 58.00%
Expected dividends | $ $ 0
Option | Minimum  
Stock options, Grant Date Fair Value Valuation  
Risk-free interest rate 0.59%
Option | Maximum  
Stock options, Grant Date Fair Value Valuation  
Risk-free interest rate 0.94%
Market options  
Stock options, Shares  
Outstanding at the beginning of the period (in shares) | shares 700,209
Granted (in shares) | shares 0
Exercised (in shares) | shares 0
Forfeited (in shares) | shares 0
Expired (in shares) | shares 0
Outstanding at the end of the period (in shares) | shares 700,209
Options exercisable at the end of the period (in shares) | shares 0
Stock options, Weighted Average Exercise Price  
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 236.01
Granted (in dollars per share) | $ / shares 0
Exercised (in dollars per share) | $ / shares 0
Forfeited (in dollars per share) | $ / shares 0
Expired (in dollars per share) | $ / shares 0
Outstanding at the end of the period (in dollars per share) | $ / shares 236.01
Options exercisable at the end of the period (in dollars per share) | $ / shares $ 0
Stock options, Weighted Average Remaining Contractual Term  
Outstanding at the end of the period 7 years 6 months
Options exercisable at the end of the period 0 years
Stock options, Aggregate Intrinsic Value  
Outstanding at the end of the period | $ $ 11,759,000
Options exercisable at the end of the period | $ $ 0
Stock options, Grant Date Fair Value Valuation  
Maximum number of shared to be earned | shares 1,169,349
Percentage of target number of shares 167.00%
Performance awards earned (in shares) | shares 481,669